CAIRO PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss

The total revenue of CPCI for the last quarter is 336.36 M EGP, and it's 9.93% lower compared to the previous quarter. The net income of Q3 24 is 74.55 M EGP.